Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis

NCT02732314 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic
Eczema

Interventions

DRUG: Investigational OTC Cream
OTHER: Cosmetic Eczema Cream
DRUG: 0.05% Desonide Cream
OTHER: Placebo Cream

Sponsor

Procter & Gamble Beauty